The first direct evidence of anti-PDGFR antibody pathogenicity was instead demonstrated in a skin-humanized severe combined immunodeficiency mouse model engrafted with skin biopsies of healthy donors injected with total IgG purified from the serum of SSc patients [105]. The gene discussed is PDGFRB; the disease is systemic sclerosis.